Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nimotuzumab

EU orphan designation number: EU/3/08/550   
Active ingredient: Nimotuzumab
Indication: Treatment of pancreatic cancer
Sponsor: Oncoscience AG
Hafenstraße 32, D-22880 Wedel, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Centralised Orphan - Designation EMEA/OD/006/08 (2008)2538 of 03/06/2008